Αναζήτηση Δραστικών

RASBURICASE

ATC

Εμπορικές Ονομασίες

  • DRUGBANK - Rasburicase
  • indication:

    For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy)

  • pharmacology:

  • mechanism:

    Rasburicase catalyzes enzymatic oxidation of uric acid into an inactive and soluble metabolite (allantoin).

  • toxicity:

  • absorprion:

  • halflife:

    18 hours

  • roouteelimination:

  • volumedistribution:

    * 110 to 127 mL/kg [pediatric patients] * 75.8 to 138 mL/kg [adult patients]

  • clearance: